Please login to the form below

Not currently logged in
Email:
Password:

Sameer Goel leaves GSK for Cipla

He is appointed country head, India
Cipla Sameer Goel

Cipla has appointed GlaxoSmithKline (GSK) veteran Sameer Goel as country head for its operations in India.

Goel spent 26 years at GSK, gaining senior experience in the emerging markets in India and Africa.

He most recently served as general manager for GSK in Africa, leading a $0.4bn business based in South Africa. He established Africa as a new region for the company, and has worked to set out GSK as a leader in the region.

Previous roles at GSK include managing director for West Africa and VP, sales, for the Indian sub-continent.

This experience in India will be valuable in his new role at Cipla, which is one of the leading domestic drug companies in the country.

Cipla's managing director and CEO Subhanu Saxena said: “This appointment signals the continuation of Cipla's strategy of strengthening the highly experienced senior management team and to show our strong determination to increase the market share in India.”

23rd January 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics